What Is the Most Venomous Snake? Comparing Venom Toxicity

The most venomous snake, measured by venom toxicity in laboratory animals, is the inland taipan (Oxyuranus microlepidotus), also called the small-scaled snake or fierce snake. Its murine LD50 value of 0.01 mg/kg is the lowest recorded for any snake, meaning a very small amount of its venom kills half of tested mice. This ranking, however, answers a narrow scientific question about venom potency in rodents. It does not answer which snake kills the most humans, which snake delivers the most venom in a bite, or which snake poses the greatest danger where you live. This article explains how venom toxicity is measured, why the inland taipan leads the LD50 rankings, which other species are close contenders, and why venom toxicity alone is a poor predictor of human risk.

At a Glance: Top Contenders by Venom Toxicity

The table below ranks well-known venomous snakes by reported murine LD50 values. Lower numbers indicate higher toxicity. The values come from different studies using different routes of injection, so direct comparisons require caution.

The inland taipan and many-banded krait values come from peer-reviewed studies. The belcher's sea snake value is widely repeated in popular sources but does not appear in the approved evidence packet with a specific number. The white-lipped pit viper and green parrot snake values come from studies that used defined methods and are included to show the wide range of toxicity across species.

How Venom Toxicity Is Measured

The LD50 Test

Venom toxicity is most often expressed as the median lethal dose, abbreviated LD50. This is the dose of venom, per unit of body weight, that kills 50 percent of a test animal population under defined conditions. Lower LD50 values mean higher toxicity. The test is usually performed in mice, and the route of injection matters. Common routes include intravenous, intraperitoneal, subcutaneous, and intramuscular injection.

The LD50 value is not a fixed biological constant for a species. It changes with the test animal, the injection route, the venom batch, and the laboratory performing the test. A study of the many-banded krait found that LD50 values for beta-bungarotoxin depended strongly on the injection route, while values for alpha- and gamma-bungarotoxin did not change with the route. This means a single number cannot fully describe how toxic a venom is, and comparing LD50 values across studies requires attention to methods.

Why the Inland Taipan Leads the Rankings

The inland taipan was rediscovered and studied in the early 1980s. A 1983 study in the Journal of Toxicology. Clinical Toxicology reported a murine LD50 of 0.01 mg/kg for this species, the lowest recorded for any snake at that time. The same study measured the average venom mass delivered in a strike at 17.3 mg and calculated an injected mass to LD50 ratio of 1730, the highest recorded for any snake studied. This ratio is an index of potential human lethality because it compares how much venom a snake actually injects against how much is needed to kill a test animal.

The inland taipan venom contains at least six identified protein fractions, and one or more of these has potent neurotoxic action. The study also found that an average of 0.6 mg of venom is spilled on the skin surface during a strike, and 40 percent of that can be recovered within three hours after a simulated bite. This skin venom is enough for accurate species diagnosis in human snakebite cases.

The Many-Banded Krait as a Close Contender

A 2024 study in Toxins reported an LD50 of 0.0133 μg/g for the many-banded krait (Bungarus multicinctus), which converts to 0.0133 mg/kg. This is very close to the inland taipan value. The same study reported an LD50 of 0.752 μg/g for the larger black-tailed krait (Bungarus bungaroides), showing that toxicity varies substantially even within the same genus.

The many-banded krait is described as the most venomous snake distributed in China and neighboring countries of Myanmar, Laos, north Vietnam, and Thailand. Its high mortality rate is attributed to the lethal components of alpha-, beta-, gamma-, and kappa-bungarotoxins in its venom. A 2020 study in PLoS Neglected Tropical Diseases found that commercial antivenin against this species showed strong immunoreaction with high molecular weight venom fractions but weakly recognized low molecular weight fractions like alpha- and gamma-bungarotoxins. This is a practical concern because it means the antivenin may not neutralize all lethal components effectively.

Venom Toxicity Versus Human Danger

Why LD50 Does Not Predict Human Risk

Venom toxicity in mice is a laboratory measurement. Human danger depends on many additional factors. These include the amount of venom injected in a bite, the efficiency of the venom delivery system, the behavior and habitat of the snake, the likelihood of human encounter, the speed of medical care, and the availability of effective antivenom.

The inland taipan lives in remote desert regions of central Australia. It is shy and avoids humans. Bites are extremely rare. In contrast, the white-lipped pit viper has a much higher LD50 of 5.09 mg/kg but is responsible for a high number of bite cases in Indonesia according to WHO data cited in a 2021 study. A snake with less toxic venom can cause more human harm if it bites more people.

Venom Yield and Injected Dose

The amount of venom a snake injects matters as much as the toxicity of that venom. The 1983 inland taipan study measured an average injected mass of 17.3 mg per strike. With an LD50 of 0.01 mg/kg, a single strike from an inland taipan contains enough venom to kill a very large number of laboratory mice. The study described this injected mass to LD50 ratio as the highest recorded for any snake.

Venom yield varies within a species and even within an individual snake. Factors include the snake's size, age, time since last feeding, and the nature of the threat. A snake may deliver a dry bite with no venom, or it may inject only a fraction of its available venom. This variability makes field predictions of human lethality unreliable.

Geographic and Ecological Context

Snake species are not evenly distributed across the globe. The snakes that cause the most human deaths are those that live near people, are abundant, and are likely to be stepped on or provoked. A 2024 systematic review in Toxicon noted that snakebite envenomation is a neglected tropical disease with approximately 1.8 million cases annually. The review emphasized that venom composition varies across species and geographical locations, which limits the cross-neutralization activity of current antivenoms.

The same review found that elapid venoms are predominated by three-finger toxins and phospholipase A2, while viper venoms show more diversity with widespread dominance of snake venom metalloproteinases and snake venom serine proteases. This compositional variation matters for treatment because antivenom developed against one species may not work against another species with a different venom profile.

The Belcher's Sea Snake Question

What the Evidence Shows

The belcher's sea snake is frequently described in popular media as the most venomous snake in the world. The approved evidence packet does not contain a specific LD50 value for this species. A PubMed bibliographic record titled "Sea Snake Toxicity" exists, and a 1987 study in Annals of Emergency Medicine titled "Biotoxicology of sea snake venoms" provides general information about sea snake toxicity.

The 1987 study states that sea snakes are the most abundant venomous reptiles, found throughout the Indian and Pacific Oceans. They are divided into two subfamilies, Laticaudinae and Hydrophiinae, and all sea snakes are poisonous. Their venoms are highly toxic, as indicated by low LD50 values in test animals. Toxic compounds include presynaptic and postsynaptic neurotoxins. The clinical syndrome following a bite is largely neurotoxic and myotoxic, with rare hepatotoxicity and nephrotoxicity.

Why the Belcher's Sea Snake Is Not the Clear Winner

The claim that the belcher's sea snake is the most venomous snake does not appear in the approved evidence with a specific LD50 value. The 1987 study confirms that sea snake venoms are highly toxic with low LD50 values, but it does not rank individual species. The inland taipan has a published, specific LD50 value of 0.01 mg/kg from a peer-reviewed study. Without a comparable published value for the belcher's sea snake, the inland taipan remains the best-supported answer to the question of which snake has the most toxic venom.

Human risk from sea snakes is also low because these snakes are marine, avoid humans, and have small fangs that may not penetrate wetsuits or clothing effectively. The 1987 study notes that proper emergency field therapy and timely administration of antivenin can be lifesaving for sea snake bites, and hemodialysis may be useful when antivenin is not available.

Other Notable Contenders

Kraits of the Genus Bungarus

The genus Bungarus contains several species with highly toxic venoms. The many-banded krait has an LD50 of 0.0133 mg/kg, very close to the inland taipan. The black-tailed krait has an LD50 of 0.752 mg/kg, considerably higher. A 2024 study in Toxins analyzed the venom composition of both species and found that three-finger toxins and phospholipase A2 dominate their venoms. The study identified 102 venom-related proteins from 18 functional families in the many-banded krait and 99 proteins from 17 families in the black-tailed krait.

Krait bites are a serious medical problem in parts of Asia. The 2024 systematic review in Toxicon noted inter-regional differences in Bungarus sp. venoms, which complicates antivenom development. A bite from a krait may cause little local pain or swelling, which can delay treatment seeking. The neurotoxic effects can progress to respiratory failure.

Cobras and King Cobra

Cobra venoms are predominated by three-finger toxins and phospholipase A2 according to the 2024 Toxicon review. The king cobra (Ophiophagus hannah) is the longest venomous snake in the world and can deliver a large volume of venom. A 2020 study on the many-banded krait antivenin found that the antivenin demonstrated animal protection efficacy against king cobra venom but not against the venoms of the banded krait or the Chinese cobra, despite showing immunoreaction with high molecular weight fractions of all three.

A 2026 study in PLoS Neglected Tropical Diseases examined short-chain alpha-neurotoxins in Asiatic cobras including Naja atra, Naja philippinensis, and Naja samarensis. The study found marked antigenic variation in these toxins that can limit the effectiveness of regional antivenoms. The Philippine Cobra Antivenom bound strongly to the homologous Philippine cobra toxin but showed significantly lower cross-reactivity with toxins from other cobra species. This means a person bitten by a cobra in one region may not be fully protected by antivenom produced for cobras in another region.

Rattlesnakes and Vipers

Viper venoms are more diverse than elapid venoms. The 2024 Toxicon review found widespread dominance of snake venom metalloproteinases and snake venom serine proteases in viper venoms. These components produce hemotoxic and cytotoxic effects instead of the neurotoxic effects typical of elapids.

The tropical rattlesnake (Crotalus durissus terrificus) accounts for the highest number of fatal envenomations in Brazil and is responsible for the second highest number of bites according to a 2022 study in the Journal of Proteomics. Its venom exhibits neurotoxic, myotoxic, hemotoxic, nephrotoxic, and cardiotoxic properties. The study injected venom at half the lethal dose into mouse gastrocnemius muscle and found changes in the abundance of more than 1300 cardiac proteins, suggesting that venom components act synergistically to cause tissue damage.

The Amazonian lancehead (Bothrops atrox) is the most important snake involved in human envenomings in the Amazon according to a 2026 study in PLoS Neglected Tropical Diseases. The study used a chicken chorioallantoic membrane model to show that the venom causes dose- and time-dependent vascular disruption, including vascular rupture and hemorrhage. At high doses, histopathology revealed endothelial disorganization, vessel dilation, leukocyte infiltration, and microthrombi formation. The study underscored the importance of early antivenom administration.

Venom Composition and Mechanisms of Toxicity

Neurotoxins

Neurotoxins are the primary lethal components in elapid and sea snake venoms. A 2002 review in Clinical and Experimental Pharmacology & Physiology classified neurotoxins according to their site of action. Presynaptic neurotoxins display varying phospholipase A2 activities and have been identified in the venoms of the four major families of venomous snakes: Crotalidae, Elapidae, Hydrophiidae, and Viperidae. These toxins produce a triphasic effect on acetylcholine release. Postsynaptic neurotoxins are antagonists of the nicotinic receptor on skeletal muscle and are subdivided into short- and long-chain toxins based on sequence. Postsynaptic neurotoxins have only been identified in venoms from the families Elapidae and Hydrophiidae.

The 1987 sea snake study identified both presynaptic and postsynaptic neurotoxins in sea snake venoms. The clinical syndrome following a sea snake bite is largely neurotoxic and myotoxic. This means a victim may experience paralysis and muscle damage, with respiratory failure as the main life-threatening complication.

Phospholipase A2 and Metalloproteinases

Phospholipase A2 enzymes are major components of many snake venoms. A 2024 study in Military Medicine tested doxycycline as an inhibitor of phospholipase A2 and snake venom metalloproteinases in three phylogenetically distinct snakes: the cottonmouth (Agkistrodon piscivorus), the monocled cobra (Naja kaouthia), and Russell's viper (Daboia russelii). The study found that phospholipase A2 activity was reduced to 1.5 to 44 percent of control levels in a dose-dependent manner, and snake venom metalloproteinase activity was reduced to 4 to 62 percent. This research is relevant to the development of small-molecule inhibitors as potential treatments for snakebite, though antibody-based antivenom remains the standard of care.

Snake venom metalloproteinases are among the most potent toxins in viper venoms according to a 2026 study in eLife. These enzymes cause hemorrhage and coagulopathy. The study developed a method to produce recombinant zymogens of all three structurally variable SVMP classes, which enables detailed study of their mechanisms. This research may lead to new therapeutic approaches for snakebite.

Variation Within and Between Species

Venom composition varies within a species across geographical locations. The 2024 Toxicon review found that population proteomics demonstrate higher diversities in the predominant venom toxins. Inter-regional differences were observed in Bungarus sp., Naja sp., Calliophis sp., and Ophiophagus hannah venoms. Intra-regional variation was only significantly observed in Naja naja venoms.

This variation has practical consequences for antivenom production and treatment. Antivenom developed against venom from snakes in one region may not neutralize venom from the same species in another region. The 2026 cobra study demonstrated this problem directly by showing that regional antivenoms had limited cross-reactivity with short-chain alpha-neurotoxins from different cobra lineages.

Practical Assessment Steps for Researchers and Clinicians

Step 1: Identify the Species

Accurate species identification is the first step in assessing venom risk. The 1983 inland taipan study noted that an adequate mass of venom remains on the skin after a bite for accurate species diagnosis. In clinical settings, a killed snake or a clear photograph can help identify the species. In research settings, morphological identification should be confirmed by molecular methods when possible.

Step 2: Determine the Relevant LD50 Value

When assessing a specific venom, find the LD50 value that matches your context. Note the test animal, injection route, and venom batch. A value obtained by intravenous injection in mice may not predict toxicity by subcutaneous injection in humans. The 2020 krait study showed that LD50 values for beta-bungarotoxin depended on injection route, while values for alpha- and gamma-bungarotoxin did not.

Step 3: Consider Venom Yield

LD50 alone does not tell you how dangerous a snake is. You also need to know how much venom the snake can deliver. The 1983 inland taipan study measured an average injected mass of 17.3 mg per strike. A snake with moderately toxic venom but a large venom yield can be more dangerous than a snake with highly toxic venom and a small yield.

Step 4: Assess Human Exposure Risk

Consider the snake's habitat, behavior, and proximity to human populations. The inland taipan has the most toxic venom but lives in remote areas and avoids humans. The white-lipped pit viper has much less toxic venom but causes many bites in Indonesia. A snake that bites many people will cause more human harm than a snake with more toxic venom that rarely encounters people.

Step 5: Verify Antivenom Availability and Efficacy

Antivenom is the standard treatment for snakebite envenomation. Check whether antivenom is available for the species in question and whether it has demonstrated efficacy against that species. The 2020 krait study showed that commercial antivenin against the many-banded krait weakly recognized low molecular weight fractions like alpha- and gamma-bungarotoxins, which are lethal components. The 2026 cobra study showed that regional antivenoms may not neutralize toxins from related species in other regions.

Records and Measurements for Snakebite Management

What to Record at the Time of a Bite

Accurate records improve treatment and research. Record the time of the bite, the location on the body, the species if known, and a description of the snake. Note the circumstances of the bite, including whether the snake was provoked. Record the victim's symptoms and their time of onset. This information helps clinicians choose the appropriate antivenom and monitor for complications.

What to Measure in Venom Research

Venom research requires standardized measurements. The LD50 value is the most common measure of toxicity. Venom yield should be measured by milking snakes under controlled conditions. Proteomic analysis identifies the protein composition of venom. Enzymatic assays measure the activity of specific components like phospholipase A2 and metalloproteinases. The 2024 krait study used LC-MS/MS to identify venom proteins and enzymatic activity assays to confirm the presence of key enzymes.

Limitations of Historical Venom Samples

Historical venom samples may not retain their original toxicity. A 2020 study in Comparative Biochemistry and Physiology examined venom samples from an Ecuadorian collection that had been stored at room temperature for years. The proteomic profiles of historical venoms were very similar to fresh venoms, but the fresh batches were more lethal. Significant differences were found in myotoxic and hemorrhagic activity, while edema activity showed no significant differences. The study concluded that the venom library is valuable for research but not suitable for antivenom production due to reduced toxicological activities.

Common Failure Patterns in Venom Toxicity Assessment

Overreliance on a Single LD50 Value

A single LD50 value does not capture the full toxicity profile of a venom. Values vary with test animal, injection route, and venom batch. The 2020 krait study demonstrated route-dependent LD50 values for beta-bungarotoxin. Comparing LD50 values across studies without attention to methods can produce misleading rankings.

Confusing Venom Toxicity with Human Danger

Venom toxicity in mice does not directly translate to human danger. Human risk depends on venom yield, delivery efficiency, encounter rates, and medical care access. The inland taipan has the most toxic venom but causes few human deaths. The white-lipped pit viper has less toxic venom but causes many bites.

Ignoring Geographic Variation in Venom Composition

Venom composition varies within species across geographical locations. The 2024 Toxicon review documented inter-regional differences in several medically important Asian species. Antivenom developed for one region may not work in another. The 2026 cobra study showed that regional antivenoms had limited cross-reactivity with toxins from different lineages.

Assuming Antivenom Cross-Neutralization

Antivenom does not automatically neutralize venom from related species. The 2020 krait study found that antivenin against the many-banded krait protected against king cobra venom but not against banded krait or Chinese cobra venom, despite showing immunoreaction with high molecular weight fractions of all three. The 2026 cobra study found that the Philippine Cobra Antivenom showed minimal recognition of marine elapid short-chain neurotoxins and long-chain alpha-neurotoxins.

Welfare and Safety Context

Snakebite as a Neglected Tropical Disease

Snakebite envenomation is a neglected tropical disease with approximately 1.8 million cases annually according to the 2024 Toxicon review. The currently available treatment is antivenom, but current antivenoms have limited cross-neutralization activity due to variations in venom composition across species and geographical locations. This makes snakebite a persistent public health problem in many regions.

The Importance of Early Treatment

Early antivenom administration is critical for snakebite outcomes. The 2026 Bothrops atrox study in PLoS Neglected Tropical Diseases underscored the imperative of early antivenom administration. The 1987 sea snake study noted that proper emergency field therapy and timely administration of antivenin can be lifesaving. Delays in treatment allow toxins to cause irreversible damage.

Research on New Treatments

Research is ongoing to develop new treatments for snakebite. The 2024 Military Medicine study tested doxycycline as an inhibitor of phospholipase A2 and metalloproteinases. The 2026 eLife study developed recombinant zymogens for studying metalloproteinase mechanisms. A 2026 study in Toxicon: X evaluated repurposed sPLA2 inhibitors as candidate snakebite therapeutics. The study found that in vitro efficacy did not translate to survival in an in vivo mouse model, highlighting the importance of preclinical studies in drug candidate selection.

Professional Escalation Criteria

When to Seek Expert Consultation

Clinicians managing snakebite cases should seek expert consultation when the species is unknown, when symptoms are severe or progressing rapidly, when antivenom is not available or its efficacy is uncertain, or when the patient is a child, pregnant, or has significant comorbidities. Poison control centers and clinical toxicologists can provide guidance on antivenom selection and dosing.

When to Report to Public Health Authorities

Snakebite cases should be reported to public health authorities, especially in regions where snakebite is a known problem. Reporting helps track incidence, identify high-risk areas, and guide antivenom distribution. The 2006 study on snakebite intoxication in the Republic of Guinea and the 2015 study on venomous snakes and snakebites in Jordan illustrate the value of regional epidemiological data.

When to Escalate in Research Settings

Researchers studying venom toxicity should escalate to specialized laboratories when they lack the equipment or expertise for specific analyses. Proteomic analysis requires mass spectrometry. Enzymatic assays require specific substrates and controls. LD50 testing requires animal ethics approval and appropriate facilities. The 2024 krait study used LC-MS/MS for proteomic analysis and standard assays for enzymatic activity, demonstrating the range of techniques required for comprehensive venom characterization.

Frequently Asked Questions

Is the inland taipan the most venomous snake in the world?

Yes, based on published LD50 values. A 1983 study in the Journal of Toxicology. Clinical Toxicology reported a murine LD50 of 0.01 mg/kg for the inland taipan (Oxyuranus microlepidotus), the lowest recorded for any snake. This value has not been surpassed by a comparable published study in the approved evidence.

Why do some sources say the belcher's sea snake is the most venomous?

Popular sources often repeat this claim, but the approved evidence does not contain a specific LD50 value for the belcher's sea snake. A 1987 study in Annals of Emergency Medicine confirms that sea snake venoms are highly toxic with low LD50 values, but it does not rank individual species. Without a comparable published value, the inland taipan remains the best-supported answer.

What does LD50 mean in snake venom research?

LD50 is the median lethal dose, the amount of venom per unit of body weight that kills 50 percent of a test animal population under defined conditions. Lower values mean higher toxicity. The value depends on the test animal, injection route, and venom batch, so comparisons across studies require attention to methods.

Does the most venomous snake cause the most human deaths?

No. Human deaths depend on many factors beyond venom toxicity, including venom yield, encounter rates, and medical care access. The inland taipan has the most toxic venom but lives in remote areas and rarely bites humans. Snakes like the white-lipped pit viper cause more bites despite having less toxic venom.

How much venom does a snake inject in a bite?

Venom yield varies by species and individual. The 1983 inland taipan study measured an average injected mass of 17.3 mg per strike. Other species deliver different amounts. A snake may also deliver a dry bite with no venom. Venom yield is an important factor in human danger that is separate from venom toxicity.

Why does antivenom not work for all snakebites?

Antivenom is species-specific and often region-specific. Venom composition varies within and between species across geographical locations. The 2020 krait study found that antivenin against the many-banded krait did not protect against banded krait or Chinese cobra venom despite showing immunoreaction. The 2026 cobra study found that regional antivenoms had limited cross-reactivity with toxins from different cobra lineages.

Are sea snake bites common?

Sea snake bites are relatively rare because these snakes are marine and avoid humans. The 1987 study in Annals of Emergency Medicine notes that sea snakes are the most abundant venomous reptiles, found throughout the Indian and Pacific Oceans. Bites occur mainly in fishermen who handle nets. Proper emergency field therapy and timely antivenin administration can be lifesaving.

How is venom toxicity measured in the laboratory?

Venom toxicity is measured by determining the LD50 in test animals, usually mice. The venom is injected by a defined route, and the dose that kills 50 percent of the animals is calculated. Additional methods include proteomic analysis to identify venom components and enzymatic assays to measure the activity of specific toxins. The 2024 krait study used LC-MS/MS for proteomic analysis and enzymatic activity assays for key venom enzymes.

Related Articles

• Difference Between Dna And Rna
• Animal Biology
• Animal Research

References and Further Reading

• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.
• Sea Snake Toxicity.. 2026.
• Biotoxicology of sea snake venoms.. Annals of emergency medicine, 1987.
• Deciphering toxico-proteomics of Asiatic medically significant venomous snake species: A systematic review and interactive data dashboard.. Toxicon : official journal of the International Society on Toxinology, 2024.
• Doxycycline-Mediated Inhibition of Snake Venom Phospholipase and Metalloproteinase.. Military medicine, 2024.
• In vitro neuromuscular activity of snake venoms.. Clinical and experimental pharmacology & physiology, 2002.
• Studies on the venom of Oxyuranus microlepidotus.. Journal of toxicology. Clinical toxicology, 1983.
• Proteomic analysis reveals rattlesnake venom modulation of proteins associated with cardiac tissue damage in mouse hearts.. Journal of proteomics, 2022.
• Proteomic Profiling of Venoms from Bungarus suzhenae and B. bungaroides: Enzymatic Activities and Toxicity Assessment.. Toxins, 2024.
• Purified zymogens reveal mechanisms of snake venom metalloproteinase auto-activation.. 2026.
• Early vascular toxicity induced by Bothrops atrox venom in the chorioallantoic membrane assay: Kinetic profile and translational insights.. 2026.
• Antigenic divergence of cobra short-chain α-neurotoxins: Implications for regional antivenom effectiveness in Southeast Asia.. 2026.
• &lt,i&gt,In vitro&lt,/i&gt,-&lt,i&gt,in vivo&lt,/i&gt, discord: A preclinical study of AZD2716 and its racemate with comparison to varespladib for the development of snake venom sPLA2 inhibitors.. 2026.
• [The problem of intoxication in the population of the Republic of Guinea due to venomous snake bites].. Meditsinskaia parazitologiia i parazitarnye bolezni, 2006.
• Is the South American water snake Helicops Angulatus (Linnaeus, 1758) (Ddipsadidae:Xenodontinae) venomous?. 2012.
• Immunoreactivity and neutralization study of Chinese Bungarus multicinctus antivenin and lab-prepared anti-bungarotoxin antisera towards purified bungarotoxins and snake venoms. PLoS Neglected Tropical Diseases, 2020.
• Assessing the stability of historical and desiccated snake venoms from a medically important Ecuadorian collection.. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2020.
• Acute Toxicity Test Of The Green Viper Snake (Trimeresurus albolabris), Macroscopic Description Of The Kidney And Liver Of Mice (Mus musculus). Journal of Basic Medical Veterinary, 2021.
• Investigation of the inhibitory potential of phospholipase A2 inhibitor gamma from Sinonatrix annularis to snake envenomation. Toxicon, 2017.
• Assessment of the potential toxicological hazard of the Green Parrot Snake (Leptophis ahaetulla marginatus): Characterization of its venom and venom-delivery system. Toxicon, 2018.
• Sea Snake Toxicity. 2020.
• Venomous snakes and snakebites in Jordan. Toxinology Clinical Toxinology in Asia Pacific and Africa, 2015.
• The problem of intoxication in the population of the Republic of Guinea due to venomous snake bites. Meditsinskaia Parazitologiia I Parazitarnye Bolezni, 2006.
• Research Paper Acute Venom Toxicity Determinations for Five Iranian Vipers and a Scorpion. Iranian Journal of Toxicology, 2022.
• Neutralization of Viperidae and Elapidae snake venoms by sera of different animals. Toxicon, 1977.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.